发明名称 HIV-1 ENV FRAGMENT FUSION PROTEIN
摘要 2071858 9109872 PCTABS00005 Highly conserved polypeptide sequences derived from gp4l and gp 120, preferably from eleven to twenty-one amino acids in length, are joined (for example, via DNA recombinant techniques) to a non-HIV protein or polypeptide sequence comprising an amino-acid sequence not naturally encoded by the HIV genome, thereby forming a fusion protein. Such fusion proteins possess attributes that make them suitable for use in the diagnosis, treatment and prevention of HIV infection.
申请公布号 CA2071858(A1) 申请公布日期 1991.06.14
申请号 CA19902071858 申请日期 1990.12.13
申请人 UNIVAX BIOLOGICS, INC.;SHAFFERMAN, AVIGDOR 发明人 SHAFFERMAN, AVIGDOR
分类号 A61K39/21;A61K39/00;A61K39/395;C07K1/22;C07K14/00;C07K14/16;C07K16/00;C07K19/00;C12N15/09;C12N15/49;C12P21/02;C12R1/19;G01N33/53;G01N33/569;(IPC1-7):C12N9/38;C12N9/00;C07K16/10;A61K39/42;A61K47/48 主分类号 A61K39/21
代理机构 代理人
主权项
地址